Rubella seroprevalence among women of childbearing age residing in a rual region: Is there a need for rubella vaccination in Turkey?

Japanese Journal of Infectious Diseases

Volumn 60, Issue 4, 2007, Pages 157-160

  Aksakal, F Nur ^a   Maral, Isil ^a   Cirak, Meltem Yalinay ^a   Aygun, Remzi ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PREGNANT WOMAN; QUANTITATIVE ANALYSIS; RUBELLA; RURAL POPULATION; SEROPREVALENCE; TURKEY (REPUBLIC); VACCINATION; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 34548384666     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gershon, A.-A. (2000): Rubella Virus (German Measles). p. 1708-1714. In G.L. Mandell, J.E. Bennett and R. Dolin (ed.), Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia, USA.
2. Centers for Disease Control and Prevention (2002): Rubella. p. 124-138. In W.A. Atkinson and C. Wolfe (ed.), Epidemiology and Prevention of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention, Atlanta, USA.
3. Enders, G. (1985): Serologic test combinations for safe detection of rubella infections. Rev. Infect. Dis., 7, S113-S122.
4. Noah, N.D. and Fowle, S.E. (1988): Immunity to rubella in women of childbearing age in the United Kingdom. Br. Med. J., 297, 1301-1304.
5. de Haas, R., van den Hof, S., Berbers, G.A., et al. (1999): Prevalence of antibodies against rubella virus in the Netherlands 9 years after changing from selective to mass vaccination. Epidemiol. Infect., 123, 263-270.
6. Clarke, M., Schild, G.C., Boustred, J., et al. (1979): Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet, 1, 1224-1226.
7. Ukkonen, P. (1996): Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1992. Scand. J. Infect. Dis., 28, 31-35.
8. Cutts, F.T. and Vynnycky, E. (1999): Modelling the incidence of congenital rubella syndrome in developing countries. Int. J. Epidemiol., 28, 1176-1184.
9. Cutts, F.T., Robertson, S.E., Diaz-Ortega, J.L., et al. (1997): Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: burden of disease from CRS. Bull. World Heath Organnization, 75, 55-68.
10. General Directorate of Primary Health Care of Ministry of Health of Turkey (2004): Notification and Reporting System for Communicable Diseases. Guideline for Standardized Diagnosis, Surveillance and Laboratory. General Directorate of Primary Health Care of Ministry of Health of Turkey, Ankara, Turkey.
11. General Directorate of Primary Health Care of Ministry of Health of Turkey (2006): The Annual of Statistics for 2005. General Directorate of Primary Health Care of Ministry of Health of Turkey, Ankara, Turkey.
12. Robertson, S.E., Cutts, F.T., Samuel, R., et al. (1997): Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2: vaccination against rubella. Bull. World Health Organization, 75, 69-80.
13. World Health Organization (2005): Eliminating Measles and Rubella and Preventing Congenital Rubella Infection. WHO European Region Strategic Plan 2005-2010. Copenhagen, Denmark.
14. Aksit, S., Egemen, A., Ozacar, T., et al. (1999): Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatr. Infect. Dis. J., 18, 577-580.
15. Seker, S., Abasiyanik, M.F., Salih, B.A. (2004): Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Saudi Med. J., 25, 575-579.
16. Nuhoglu, S., Unsal, A., Metintas, S., et al. (1999): Rubella susceptibility among WCBA in Eskisehir province. Turkish J. Infect., 13, 575-579 (in Turkish).
17. Cockburn, W.C. (1969): World aspects of the epidemiology of rubella. Am. J. Dis. Child., 118, 118-122.
18. Rawls, W.E., Melnick, J.L., Bradstreet, C.M.P., et al. (1967): WHO collaborative study on the seroepidemiology of rubella. Bull. World Health Organization, 37, 79-88.
19. Spika, J., Wassilak, S., Pebody, R., et al. (2003): Measles and rubella in the World Health Organization European Region: diversity creates challenges. J. Infect. Dis., 87, S191-S197.
20. Doroudchi, M., Dehaghani, A.S., Emad, K., et al. (2001): Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran. East Mediterr. Health J., 7, 28-38.
21. Hossain, A. (1989): Seroepidemiology of rubella in Saudi Arabia. J. Trop. Pediatr., 35, 169-170.
22. Younes, A.T., Elian, A. and Darwish, M.A. (1991): Rubella virus antibodies in women of childbearing age. J. Egypt Public Health Assoc., 66, 397-410.
23. Aksit, S., Timocin, A. and Turpculu, A. (1999): Rubella immunity in pregnant Turkish women. Int. J. Gynaecol. Obstet., 66, 33-34.
24. Yucel, A., Bozdayi, G. and Imir, T. (2002): Seroprevalence of TORCHE antibodies among pregnant women in Gazi University Hospital. Turkish J. Infect., 16, 279-283 (in Turkish).
25. Karakoc, G.B., Altintas, D.U., Kilinc, B., et al. (2003): Seroprevalence of rubella in school-girls and pregnant women. Eur. J. Epid., 18, 81-84.
26. Hinman, A.R., Irons, B., Lewis, M., et al. (2002): Economic analysis of rubella and rubella vaccines: a global review. Bull. World Health Organization, 80, 264-270.
27. Department of Vaccine and Biologicals, World Health Organization (2000): Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs. World Health Organization, Geneva, Switzerland.
28. Panagiotopoulos, T., Antoniadou, I. and Valassi-Adam, E. (1999): Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Br. Med. J., 319, 1462-1467.
29. Topuzoglu, A., Ozaydin, G.A.N., Cali, S., et al. (2005): Assessment of sociodemographic factors and socio-economic status affecting the coverage of compulsory and private immunization services in Istanbul, Turkey. Public Health, 119, 862-869.